Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
Funds small-molecule drug candidates from a lab bench through Phase I testing, with NIH's own chemistry and toxicology experts on call.
An academic lab can often find a promising small molecule, but rarely has the pharmacology, toxicology and manufacturing muscle to get it into a person safely — and that gap is where a lot of good candidates quietly die.
This notice funds crossing it. Small-molecule drug discovery and development work runs in the investigator's own laboratory, with access to NIH-supported subject matter experts a…
Phased cooperative-agreement support for small-molecule drug discovery and development toward clinical testing, run in the investigator's own laboratory with NIH-supported subject matter experts and contract research organizations providing medicinal chemistry, pharmacokinetics, toxicology, formulation and GMP synthesis capacity through Phase I. Biologics are excluded.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up